in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at PhRMA, Dyax, Alnylam, Avi BioPharma, Pacira, Asmacure and Xceleon.
GlaxoSmithKline (GSK) is investing more than CA$30m (€21m) to add dermatology product manufacturing capabilities and create 70 jobs at a Canadian plant.
GlaxoSmithKline (GSK) has announced plans to buy its joint venture Shenzhen GSK Neptunus Biologicals (GSKNB) to expand influenza vaccine production capacity in China.
Canadian lab services contractor Warnex posted improved results for Q1 with gains made by its bioanalytical unit offsetting a decline in its analytical services business.
Pfizer has begun what it claims is the world’s first ‘virtual’ trial and says that such innovation is needed to make sure clinical research is sustainable.
Indian drugmakers Serum Institute and Panacea Biotech have reduced what they charge the GAVI for vaccines, prompting similar commitments from several Big Pharma firm.
UK drug major GSK has entered into a ‘strategic partnership’ with MaRS Innovation, a Canadian group focused on harnessing the commercial potential of the discovery pipelines of 16 top Toronto academic institutions in its network.
Watson Pharmaceuticals has bought Greek generics firm Specifar Pharmaceuticals, bringing to an end a busy month of deal making in the non-branded drug sector.
US healthcare giant Baxter has commissioned logistics specialists Gazeley to begin construction on a new distribution warehouse just outside Lyon, France.
Irish pharma giant Elan is investing $20m (€14m) in US drug developer Proteostasis Therapeutics to speed the research and development of disease modifying, small molecule drugs and diagnostics for the treatment of neurodegenerative disorders.
Biologics Process Development, a wholly-owned subsidiary of Californian contract research organisation (CRO), Viropro, has announced it is to double the size of its bioprocess and scale-up laboratory.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Sanofi Pasteur, Klöckner Pentaplast and Geron.
Pharma needs to learn from other sectors and abandon the multistage development paradigm in favour of a two-stage design and manufacturing model to cut attrition rates.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at RxTrials, BASi, Novella and Premier Research.
Clinical Financial Services (CFS), a US financial management company specialising in clinical trial management, has launched its new Site Activation Services offering, designed to ‘streamline and automate’ the trial activation process.
UK-based drugmaker Shire has unveiled plans to buy Advanced BioHealing (ABH) citing the lack of generic competition in the regenerative medicines sector as a factor.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Aphena, Acino and blue inspection body.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Icon, Quintiles, Catalent and CRF Health.
Phlexglobal, a contract research organisation (CRO) specialising in trial master file (TMF) and eTMF management, has expanded its US operations with the opening of an office in Philadelphia, Pennsylvania.
EMD Millipore has opened a training facility in China as an education resource for the country’s rapidly expanding biopharmaceutical manufacturing and development sector.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Penn Pharma, Almac and Beardsworth.
A new direct flight between London Heathrow and San Diego from 1st June 2011 will benefit the international biotech sector according to UK-based Biotec Services International.
Pharma industry wishful thinking and the fact too many developers have been chasing too few targets are behind an increase in Phase II failures in recent years according to a new study.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at CMC Biologics, PharmaNet and AAIPharma.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Savient, Avantor Performance Materials and CorePharma.
Royal DSM NV says its pharmaceutical contract manufacturing business model is ‘out of step with market needs’ after the unit’s Q1 performance blots an otherwise positive set of financials.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Cetero, Harlan, Numerate and Idea Pharma.
US-based vaccine specialist, Caliber Biotherapeutics, has opened the world’s largest modular, plant-made pharmaceutical manufacturing facility at its headquarters in Bryan, Texas.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Novella and Publicis.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Raptor, Regulus, Novavax and Symphogen.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at A10, Crystal Pharmatech and Algos.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new role for former Genzyme CEO and a leadership change at Astellas Europe.
US drugmaker Amgen has acquired Brazilian manufacturer Bergamo in a bid to improve its access to ‘one of the fastest growing pharmaceutical markets in the world.”